Please login to the form below

Not currently logged in
Email:
Password:

cell and gene therapies

This page shows the latest cell and gene therapies news and features for those working in and with pharma, biotech and healthcare.

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus

maintained there are opportunities in developing the next-generation of therapies which will work in combination with these drugs. ... Barron has also indicated GSK’s interest in cell and gene therapies, which is another reversal on a previous strategy

Latest news

More from news
Approximately 3 fully matching, plus 48 partially matching documents found.

Latest Intelligence

  • A market-adapted agile approach to launch excellence A market-adapted agile approach to launch excellence

    Niche areas have seen a rise in novel approaches, gene and cell therapies, and digital therapies, creating new challenges like stakeholder educational gaps, supply chain barriers. ... Technology enables creative metrics informing agile adaptations and

  • Rethinking trials: the pros and cons of protocol amendments Rethinking trials: the pros and cons of protocol amendments

    Product complexity. The drug industry’s evolution from a provider of chemical-based medicine into a developer of larger molecule drugs and cell and gene therapies is likely to result in ... For example, in the case of a failing lot of autologous cell

  • Assessing the risks in annuity pricing models Assessing the risks in annuity pricing models

    The number of companies targeting the development of new cell and gene therapies has risen dramatically in recent years. . ... Among ten new cell and gene therapies approved in Europe since 2009, only seven are still commercially available today.

  • Evolution or revolution: the latest review of NICE methods Evolution or revolution: the latest review of NICE methods

    What’s in scope: hot topics including cell and gene therapies and HSTs. ... These include personalised medicine, digitalisation of health, and cell and gene therapies.

  • Gene therapy market access Q&A Gene therapy market access Q&A

    Jesper Jorgensen, Health Economics and Market Access Manager, Cell and Gene Therapy Catapult gives his personal view on how to get the new therapies to patients. ... My job is to understand what it takes to get a product reimbursed, and how developers of

More from intelligence
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest appointments

  • Health comms agency emotive hires new cell and gene therapy leader Health comms agency emotive hires new cell and gene therapy leader

    An expert in cell and gene therapies, Dr Ferrari joins emotive following 20 years in research as well as holding medical affairs and commercial roles in biopharma and diagnostics. ... It is also charged with developing HCP engagement on gene silencing

  • Abeona Therapeutics appoints new additions to board of directors Abeona Therapeutics appoints new additions to board of directors

    Stefano Buono and Richard Van Duyne join the biopharma. Abeona Therapeutics, a clinical stage biopharmaceutical company focused on developing cell and gene therapies, has expanded its board of directors through the ... He said: “Abeona’s ambitious

  • Avita Medical appoints CEO Avita Medical appoints CEO

    chief scientific officer, global business development and licensing, and chief scientific officer for its cell and gene therapy unit. ... and gene therapies for Novartis subsidiaries Systemix Inc.

  • Paul Blake joins Oxford BioMedica Paul Blake joins Oxford BioMedica

    He will head the clinical development of the company's pipeline of gene and cell therapies. ... therapies will be important to Oxford BioMedica as we continue to develop our broad pipeline of novel gene and cell therapies.”.

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics